BETA

Awaiting Council decision on delegated act



2014/2759(DEA) Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use
RoleCommitteeRapporteurShadows
Lead ENVI
Lead committee dossier: ENVI/8/00856

Activites

  • 2014/11/25 Delegated act not objected by Parliament
  • 2014/09/17 Committee referral announced in Parliament, 1st reading/single reading
  • 2014/09/16 Initial period for examining delegated act extended at Parliament's request by 2 month(s)
  • 2014/07/17 Initial period for examining delegated act 2 month(s)
  • 2014/05/28 Non-legislative basic document published
    • C(2014)03446

Documents

  • Non-legislative basic document published: C(2014)03446

History

(these mark the time of scraping, not the official date of the change)

activities
  • date: 2014-05-28T00:00:00 docs: type: Non-legislative basic document published title: C(2014)03446 body: EC commission: type: Non-legislative basic document published
  • date: 2014-07-17T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s)
  • date: 2014-09-16T00:00:00 body: EP/CSL type: Initial period for examining delegated act extended at Parliament's request by 2 month(s)
  • date: 2014-09-17T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
  • date: 2014-11-25T00:00:00 body: EP/CSL type: Delegated act not objected by Parliament
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
committees/0
body
EP
responsible
True
committee_full
Environment, Public Health and Food Safety
committee
ENVI
docs
  • date: 2014-05-28T00:00:00 docs: title: C(2014)03446 type: Non-legislative basic document body: EC
  • date: 2015-07-06T00:00:00 docs: title: C(2015)4742 type: Document attached to the procedure body: EC
  • date: 2015-10-05T00:00:00 docs: title: C(2015)6791 type: Document attached to the procedure body: EC
events
  • date: 2014-05-28T00:00:00 type: Non-legislative basic document published body: EC docs: title: C(2014)03446
  • date: 2014-07-17T00:00:00 type: Initial period for examining delegated act 2 month(s) body: EP/CSL
  • date: 2014-09-16T00:00:00 type: Initial period for examining delegated act extended at Parliament's request by 2 month(s) body: EP/CSL
  • date: 2014-09-17T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2014-11-25T00:00:00 type: Delegated act not objected by Parliament body: EP
links
other
    procedure/dossier_of_the_committee
    Old
    ENVI/8/00856
    New
    • ENVI/8/00856
    procedure/subject
    Old
    • 4.20.04 Pharmaceutical products and industry
    New
    4.20.04
    Pharmaceutical products and industry
    procedure/summary
    • Supplementing
    activities/4
    date
    2014-11-25T00:00:00
    body
    EP/CSL
    type
    Delegated act not objected by Parliament
    procedure/stage_reached
    Old
    Awaiting committee decision
    New
    Awaiting Council decision on delegated act
    activities
    • date: 2014-05-28T00:00:00 docs: type: Non-legislative basic document published title: C(2014)03446 type: Non-legislative basic document published body: EC commission:
    • date: 2014-07-17T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s)
    • date: 2014-09-16T00:00:00 body: EP/CSL type: Initial period for examining delegated act extended at Parliament's request by 2 month(s)
    • date: 2014-09-17T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
    committees
    • body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
    links
    other
      procedure
      dossier_of_the_committee
      ENVI/8/00856
      reference
      2014/2759(DEA)
      title
      Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use
      stage_reached
      Awaiting committee decision
      summary
      Supplementing
      subtype
      Examination of delegated act
      type
      DEA - Delegated acts procedure
      subject
      4.20.04 Pharmaceutical products and industry